Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Kimberly-Clark, manufacturer of consumer goods and personal care products, is best known for its paper-based products, ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

The deal, expected to close in the second half of 2026, comes as Kenvue's Tylenol political fight is heating up.

Kimberly-Clark Corp, the company behind popular brands like Kleenex and Huggies, has announced its plan to acquire Kenvue Inc ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, ...

IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...

In what is being called one of the largest corporate takeovers in years, Kimberly-Clark is buying Tylenol parent company, ...

The transaction, structured as a mix of cash and stock, represents an equity value of about USD 40 billion, excluding debt.